Current trends in local antibacterial therapy of periprosthetic infection and osteomyelitis

Cover Page


Cite item

Full Text

Abstract

The rational use of antibiotics in the treatment of orthopedic infection still presents a significant problem. Local antibiotic delivery systems enable to achieve effective concentrations of drugs in the focus of bone infection without the development of toxicity. It is the important accompaniment to systemic antibiotics in the treatment of periprosthetic infection and osteomyelitis. The data collected through the PubMed and eLIBRARY databases (http://www.ncbi.nlm. nih.gov/pubmed, 1995-2015; http://elibrary.ru, 2005-2015 years) present the information about bone substitutes used for local antibiotic therapy in scientific investigations and in clinical practice. The information is submitted in accordance with the groups of materials: cements based on polymethylmethacrylate, bone grafts, demineralized bone matrix, bioceramics, natural and synthetic polymers, combined antibiotic delivery systems. The majority of these materials have only been studied experimentally and only a limited range of them is registered for use in clinical practice. Informing orthopedic surgeons about current methods of local antibiotic use is the key to the development of a modern integrated approach to the therapy of infectious complications after orthopedic surgery.

About the authors

S. A. Bozhkova

Vreden Russian Research Institute of Traumatology and Orthopedics

Author for correspondence.
Email: noemail@neicon.ru
Россия

A. A. Novokshonova

Vreden Russian Research Institute of Traumatology and Orthopedics

Email: noemail@neicon.ru
Россия

V. A. Konev

Vreden Russian Research Institute of Traumatology and Orthopedics

Email: noemail@neicon.ru
Россия

References

  1. Ардашев И.П., Черницов С.В., Веретельникова И.Ю., Бунина О.Г., Иванова О.А. Использование препарата «Коллапан» при остеомиелите позвоночника в эксперименте. Гений ортопедии. 2012; 2:44-48.
  2. Баринов С.М. Керамические и композиционные материалы на основе фосфатов кальция для медицины. Успехи химии. 2010; 79(1):15-32.
  3. Божкова С.А., Тихилов Р.М., Краснова М.В., Рукина А.Н. Ортопедическая имплантат-ассоциированная инфекция: ведущие возбудители, локальная резистентность и рекомендации по антибактериальной терапии. Травматология и ортопедия России. 2013; 4 (70):5-15.
  4. Данильченко С.Н., Калинкевич О.В., Погорелов М.В., Скляр А.М., Калиниченко Т.Г., Калинкевич А.Н., Стариков В.В., Бумейстер В.И., Сикора В.З., Суходуб Л.Ф. Экспериментальное обоснование применения композитных материалов на основе хитозана и фосфатов кальция для замещения костных дефектов. Ортопедия, травматология и протезирование. 2009; 1:66-72.
  5. Живцов О.П., Митрофанов В.Н. Применение биокомпозитных материалов при лечении пациентов с полостными формами остеомиелита. Материалы I Международного конгресса «Раны и раневые инфекции». 11-13 октября 2012 г. Москва http://woundsurgery.ru/tezis/1kongress_tezis.pdf (дата обращения 01.06.2015)
  6. Кильметов Т.А., Ахтямов И.Ф., Гальмутдинов И.Ш., Гатина Э.Б., Еремин И.К., Алиев Э. И-А., Исмаилов Х. Г-О. Локальная антибиотикотерапия при инфекции области эндопротеза сустава. Казанский медицинский журнал. 2014; 3 (95):405-411.
  7. Линник С.А., Ромашов П.П., Новоселов К.А., Хаймин В.В., Харитонов А.А., Марковиченко Р.В., Петров В.A., Кравцов А.Г., Нестеров Н.Н., Косов Д.А., Щеглов О.В., Никитин Г.Д. Применение препарата Оsteoset для заполнения костных полостей. Травматология и ортопедия России. 2009; 3(53):155-156.
  8. Лю Бо, Тихилов Р.М., Шубняков И.И., Разоренов В.Л., Денисов А.О., Божкова С.А., Артюх В.А., Клиценко О.А., Тотоев З.А. Эффективность первого этапа двухэтапной ревизии при параэндопротезной инфекции тазобедренного сустава. Травматология и ортопедия России. 2014; 3(73):5-14.
  9. Материалы международной согласительной конференции по перипротезной инфекции. Пер. с англ. под. общ. ред. Р.М. Тихилова. СПб.: РНИИТО им. Р.Р. Вредена; 2014. 355 c.
  10. Митрофанов В.Н., Живцов О.П. Опыт применения ультразвуковой кавитации при лечении пациентов с хроническим полостным остеомиелитом. Мед Альманах. 2013; 3(27):115-116.
  11. Мушкин М.А., Першин А.А., Кириллова Е.С., Мушкин А.Ю. Сравнительный рентгенологический анализ остеорепарации после радикально-восстановительных операций, проведенных с использованием различных пластических материалов у детей с деструктивными поражениями костей. Гений ортопедии. 2012; 1:102-105.
  12. Пичхадзе И.М. Кузьменков К.А., Жадин А.В., Цискарашвили А.В. Лечение больных с гнойно-воспалительными осложнениями после эндопротезирования тазобедренного сустава. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2009; 3:45-50.
  13. Amin T.J., Lamping J.W., Hendricks K.J., McIff T.E. Increasing the Elution of Vancomycin from High-Dose Antibiotic-Loaded Bone Cement: A Novel Preparation Technique. J Bone Joint Surg Am. 2012; 94:1946-1945.
  14. Anand A., Pundir R., Pandian C.S., Saraf S., Gupta H. Cefoperazone Sodium Impregnated Polycaprolactone Composite Implant for Osteomyelitis. Indian J Pharm Sci. 2009;71(4):377-381.
  15. Andersson O.H., Rosenquist J., Karlsson K.H. Dissolution, leaching, and Al2O3 enrichment at the surface of bioactive glasses studied by solution analysis. J Biomed Mater Res. 1993; 27:941-948.
  16. Barrett L., Atkins B. The clinical presentation of prosthetic joint infection. J Antimicrob Chemother. 2014; 69 (1): 25-7.
  17. Bauer TW, Parvizi J, Kobayashi N, Krebs V. Diagnosis of periprostetic infection. J Bone Joint Surg Am. 2006; 88(4): 869-882.
  18. Bertazzoni Minelli E., Benini A., Magnan B., Bartolozzi P. Release of gentamicin and vancomycin from temporary human hip spacers in two-stage revision of infected arthroplasty. J Antimicrob Chemother. 2004; 53(2): 329-334.
  19. Boskey A.L., Myers E.R. Is bone mineral crystalsize significant contributor to “bone quality”? IBMS BoneKEy-Osteovision. 2004; 1:4-7.
  20. Böstman O.M., Laitinen O.M., Tynninen O., Salminen S.T., Pihlajamäki H.K. Tissue restoration after resorption of polyglycolide and poly-laevo-lactic acid screws. J Bone Joint Surg Br. 2005; 87(11):1575-1580.
  21. Bouzakis K.D., Michailidis N., Mesomeris G., Anagnostidis K.S., Kirkos J.M., Kapetanos G.A. Investigation Of Mechanical Properties Of Antibiotics-Loaded Acrylic Bone Cement. Proceedings of the 3rd International Conference on Manufacturing Engineering (ICMEN), 1-3 October 2008, Chalkidiki, Greece.
  22. Buttaro M.A., Gimenez M.I., Greco G., Barcan L., Piccaluga F. High active local levels of vancomycin without nephrotoxicity released from impacted bone allografts in 20 revision hip arthroplasties. Acta Orthopaedica. 2005; 76(3):336-340.
  23. Campana V., Milano G., Pagano E., Barba M., Cicione C., Salonna G., Lattanzi W., Logroscino G. Bone substitutes in orthopaedic surgery: from basic science to clinical practice. J Mater Sci: Mater Med. 2014; 25:2445-2461.
  24. Corona P.S., Espinal L., Rodrнguez-Pardo D., Pigrau C., Larrosa N., Flores X. Antibiotic Susceptibility in Gram-Positive Chronic Joint Arthroplasty Infections: Increased Aminoglycoside Resistance Rate in Patients With Prior Aminoglycoside-Impregnated Cement Spacer Use. J Arthroplasty. 2014; 29(8):1617-1621.
  25. Ding H., Zhao C.J., Cui X., Gu Y.F., Jia W.T., Rahaman M.N., Wang Y., Huang W.H., Zhang C.Q. A Novel Injectable Borate Bioactive Glass Cement as an Antibiotic Delivery Vehicle for Treating Osteomyelitis. PLoS One. 2014; 9(1):e85472.
  26. DiPisa J.A., Sih G.S., Berman A.T. The temperature problem at the bone-acrylic cement interface of the total hip replacement. Clin Orthop Relat Res. 1976; 121:95-8.
  27. Drago L., Romanò D., De Vecchi E., Vassena C., Logoluso N., Mattina R., Romanò C.L. Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study. BMC Infect Dis. 2013; 13:584.
  28. Drago L., Vassena C., Fenu S., De Vecchi E., Signori V., De Francesco R., Romanò C.L. In vitro antibiofilm activity of bioactive glass S53P4. Future Microbiol. 2014; 9(5):593-601.
  29. El-Husseiny M., Patel S., MacFarlane R.J., Haddad F.S. Biodegradable antibiotic delivery systems. J Bone Joint Surg Br. 2011; 93-B:151-157.
  30. Ensing G.T., van Horn J.R., van der Mei H.C., Buss-cher H.J., Neut D. Copal Bone Cement Is More Effective in Preventing Biofilm Formation than Palacos R-G. Clin Orthop Relat Res. 2008; 466:1492-1498.
  31. Espehaug B., Engesaeter L.B., Vollset S.E., Havelin L.I., Langeland N. Antibiotic prophylaxis in total hip arthroplasty. Review of 10,905 primary cemented total hip replacements reported to the Norwegian arthroplasty register, 1987 to 1995. J Bone Joint Surg Br. 1997; 79(4):590-595.
  32. Gehrke T., Parvizi J. Proceedings of the International Consensus Meeting on Periprosthetic Joint Infection. https://www.efort.org/wp-content/uploads/2013/10/Philadelphia_Consensus.pdf (дата обращения 01.06.2015).
  33. Gitelis S., Brebach G.T. The treatment of chronic osteomyelitis with a biodegradable antibiotic-Impregnated implant. J Orthop Surg (Hong Kong). 2002; 10(1):53-60.
  34. Greish Y.E., Brown P.W. Phase evolution during the formation of stoichiometric hydroxyapatite at 37.4 degrees C. J Biomed Mater Res B Appl Biomater. 2003; 67(1):632-637.
  35. Gunatillake P.A., Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur Cell Mater. 2003; 5:1-16.
  36. Hansen E.N., Adeli B., Kenyon R., Parvizi J. Routine use of antibiotic laden bone cement for primary total knee arthroplasty: impact on infecting microbial patterns and resistance profiles. J Arthroplasty. 2014; 29(6):1123-1127.
  37. Herford A.S., Boyne P.J., Rawson R., Williams R.P. Bone morphogenetic protein-induced repair of the premaxillary cleft. J Oral Maxillofac Surg. 2007; 65 (11):2136-2141.
  38. Hettfleisch J., Schöttle H. Local preventive antibiotic treatment in intramedullary nailing with gentamycin impregnated biomaterials. Aktuelle Traumatol. 1993; 23:68-71.
  39. Jafari S.M., Coyle C., Mortazavi S.M., Sharkey P.F., Parvizi J. Revision hip arthroplasty: infection is the most common cause of failure. Clin Orthop Relat Res. 2010; 468(8):2046-2051.
  40. Jia W.T., Luo S.H., Zhang C.Q., Wang J.Q. In Vitro and In Vivo Efficacies of Teicoplanin-Loaded Calcium Sulfate for Treatment of Chronic Methicillin-Resistant Staphylococcus aureus Osteomyelitis. Antimicrob Agents Chemother. 2010; 54(1):170-176.
  41. Jiang J.L., Li Y.F., Fang T.L., Zhou J., Li X.L., Wang Y.C., Dong J. Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits. Inflamm. 2012; 61(3):207-215.
  42. Ketonis C., Adams C.S., Barr S., Aiyer A,. Shapiro I.M., Parvizi J., Hickok N.J. Antibiotic Modification of Native Grafts: Improving Upon Nature’s Scaffolds. Tissue Eng Part A. 2010; (6):2041-2049.
  43. Kurkcu M., Benlidayi M.E., Cam B., Sertdemir Y.J. Anorganic bovine-derived hydroxyapatite vs β-tricalcium phosphate in sinus augmentation: a comparative histomorphometric study. Oral Implantol. 2012; (38):519-526.
  44. Laine J.C., Nguyen T.D., Buckley J.M., Kim H.T. Effects of Mixing Techniques on Vancomycin-Impregnated Polymethylmethacrylate. The Journal of Arthroplasty; 2011; (26):1562-1566.
  45. Langlais F., Bone J. Can we improve the results of revision arthroplasty for infected total hip replacement? Joint Surg. 2003; (85):637-640.
  46. Le Ray A.M., Gautier H., Laty M.K., Daculsi G., Merle C., Jacqueline C., Hamel A., Caillon J. In vitro and in vivo bactericidal activities of vancomycin dispersed in porous biodegradable poly(epsilon-caprolactone) microparticles. Antimicrob Agents Chemother. 2005; 49(7):3025-3027.
  47. Lee G.H., Khoury J.G., Bell J.E., Buckwalter J.A. Adverse reactions to OsteoSet bone graft substitute the incidence in a consecutive series. Iowa Orthop J. 2002; (22):35-38.
  48. Lemaire S., Van Bambeke F., Pierard D., Appelbaum P.C., Tulkens P.M. Activity of fusidic acid against extracellular and intracellular Staphylococcus aureus: influence of pH and comparison with linezolid and clindamycin. Clin Infect Dis. 2011; 52(Suppl 7):S493-503.
  49. Lie S.A., Engesaeter L.B., Havelin L.I., Gjessing H.K., Vollset S.E. Dependency issues in survival analyses of 55,782 primary hip replacements from 47,355 patients. Stat Med. 2004; (23):3227-3240.
  50. Lin C., Mao C., Zhang J., Li Y., Chen X. Healing effect of bioactive glass ointment on full-thickness skin wounds. Biomed Mater. 2012; 7(4):045017.
  51. Liu X., Xie Z., Zhang C., Pan H., Rahaman MN., Zhang X., Fu Q., Huang W. Bioactive borate glass scaffolds: in vitro and in vivo evaluation for use as a drug delivery system in the treatment of bone infection. J Mater Sci Mater Med. 2010; (2):575-582.
  52. Ma T., Shang B.C., Tang H., Zhou T.H., Xu G.L., Li H.L., Chen Q.H., Xu Y.Q. Nano-hydroxyapatite/chitosan/konjac glucomannan scaffolds loaded with cationic liposomal vancomycin: preparation, in vitro release and activity against Staphylococcus aureus biofilms. J Biomater Sci Polym Ed. 2011; (12):1669-1681.
  53. Ma X., Zhao Y., Liang X.J. Theranostic nanoparticles engineered for clinic and pharmaceutics. Acc Chem Res. 2011; (10):1114-1122.
  54. Maier G.S., Roth K.E., Andereya S., Birnbaum K., Nied-hart C., Lühmann M., Ohnsorge J., Maus U. In Vitro Elution Characteristics of Gentamicin and Vancomycin from Synthetic Bone Graft Substitutes. The Open Orthopaedics Journal. 2013; (7):624-629.
  55. Masri B.A., Duncan C.P., Beauchamp C.P., Engh G.A., Rorabeck C.H. The modified two staged exchange arthroplasty in the treatment of infected total knee replacement: The Prostalac system and other articulated spacers. Revision Total Knee Arthroplasty. 1997; (13):394-424.
  56. Mendel V., Simanowski H.J., Scholz H.C., Heymann H. Therapy with gentamicin-PMMA beads, gentamicin-collagen sponge, and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats. Arch Orthop Trauma Surg. 2005; 125(6):363-368.
  57. Metsemakers W.J., Emanuel N., Cohen O., Reichart M., Potapova I., Schmid T., Segal D., Riool M., Kwakman P.H., de Boer L., de Breij A., Nibbering P.H., Richards R.G., Zaat S.A., Moriarty T.F. A doxycycline-loaded polymer-lipid encapsulation matrix coating for the prevention of implant-related osteomyelitis due to doxycycline-resistant methicillin-resistant Staphylococcus aureus. J Control Release. 2015; (209):47-56.
  58. Meyer J., Piller G., Spiegel C.A., Hetzel S., Squire M. Vacuum-mixing significantly changes antibiotic elution characteristics of commercially available antibiotic-impregnated bone cements. J Bone Joint Surg Am. 2011; 93(22):2049-2056.
  59. Michalak K.A., Khoo P.P., Yates P.J., Day R.E., Wood D.J. Iontophoresed segmental allografts in revision arthroplasty for infection. The Journal of Bone and Joint Surgery Br. 2006; (11):1430-1437.
  60. Nelson C.L., McLaren S.G., Skinner R.A., Smeltzer M.S., Thomas J.R., Olsen K.M. The treatment of experimental osteomyelitis by surgical debridement and the implantation of calcium sulfate tobramycin pellets. Journal of Orthopaedic Research. 2002; (20):643-647.
  61. Neut D., Kluin O.S., Crielaard B.J., van der Mei H.C., Busscher H.J., Grijpma D.W. A biodegradable antibiotic delivery system based on poly-(trimethylene carbonate) for the treatment of osteomyelitis. Acta Orthopaedica. 2009; (5):514-519.
  62. Neut D., van de Belt H., Stokroos I., van Horn J.R., van der Mei H.C., Busscher H.J. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. Journal of Antimicrobial Chemotherapy. 2001; (47):885-891.
  63. Nishimura S., Matsumae T., Murakami Y., Abe Y., Sasato-mi Y., Nagayoshi I., Ueda K., Nakashima H. Chronic renal failure due to amyloid nephropathy caused by chronic infection after total hip replacement. CEN Case Reports. 2014; 3(2):217-222
  64. Noel S.P., Courtney H., Bumgardner J.D., Haggard W.O. Chitosan Films A Potential Local Drug Delivery System for Antibiotics. Clin Orthop Relat Res. 2008; 466:1377-1382.
  65. Olson M., Ceri H., Morck D.V., Buret A.G., Read R.R. Biofilm bacteria: formation and comparative susceptibility to antibiotics. The Canadian Journal of Veterinary Research. 2002; (66):86-92.
  66. Ordikhani F., Tamjid E., Simchi A. Characterization and antibacterial performance of electrodeposited chitosan-vancomycin composite coatings for prevention of implant-associated infections. Mater Sci Eng C Mater Biol Appl. 2014; (1):240-248.
  67. Patel M.P., Patel R.R., Patel J.K. Chitosan Mediated Targeted Drug Delivery System: A Review. J Pharm Pharmaceut Sci. 2010; 13(3):536-557.
  68. Peel T.N., Dowsey M.M., Buising K.L., Liew D., Choong P.F.M. Cost analysis of debridement and retention for management of prosthetic joint infection. Clin Microbio Infect. 2011; (10):1469-1491.
  69. Phillips C.B., Barrett J.A., Losina E. et al. Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am. 2003; (1): 20-26.
  70. Pillai R., Somayaji S.N., Rabinovich M., Hudson M.C., Gonsalves K.E. Nafcillin-loaded PLGA nanoparticles for treatment of osteomyelitis. Biomed Mater. 2008. (3):Article ID 034114.
  71. Raschke M.J., Schmidmaier G. Biological coating of implants in trauma and orthopedic surgery. Unfallchirurg. 2004; (8):653-663.
  72. Robinson D., Alk D., Sandbank J., Farber R., Halperin N. Inflammatory reactions associated with a calcium sulfate bone substitute. Ann Transplant. 1999; (4):91-97.
  73. Scharer B.M., Sanicola S.M. The In Vitro Elution Characteristics of Vancomycin From Calcium PhosphateАCalcium Sulfate Beads. The Journal of Foot & Ankle Surgery. 2009; 48(5):540-542.
  74. Shi P., Zuo Y., Li X., Zou Q., Liu H., Zhang L., Li Y., Morsi Y.S. Gentamicin-impregnated chitosan/nanohydroxyapatite/ethyl cellulose microspheres granules for chronic osteomyelitis therapy. J Biomed Mater Res A. 2010; 93(3):1020-1023.
  75. Silverman L.D., Lukashova L., Herman O.N., Lane J.M., Boskey A.L. Release of Gentamicin from a Tricalcium Phosphate Bone Implant. Journal of orthopaedic research January. 2007; 25(1):23-29.
  76. Sørensen T.S., Sørensen A.I., Merser S. Rapid release of gentamicin from collagen sponge: in vitro comparison with plastic beads. Acta Orthop Scand. 1990; (61):353-356.
  77. Su W.Y., Chen Y.C., Lin F.H. A New Type of Biphasic Calcium Phosphate Cement as a Gentamicin Carrier for Osteomyelitis. Evidence-Based Complementary and Alternative Medicine Volume. 2013; Article ID 801374.
  78. Tunney M.M., Dunne N., Einarsson G., McDowell A., Kerr A., Patrick S. Biofilm formation by bacteria isolated from retrieved failed prosthetic hip implants in an in vitro model of hip arthroplasty antibiotic prophylaxis. Journal of Orthopaedic Research. 2007; 25(1):2-10.
  79. Turner T.M., Urban R.M., Gitelis S., Sumner D.R., Haggard W.O., Parr E. Antibiotic Delivery From Calcium Sulfate As A Synthetic Bone Graft In A Canine Defect. Trans Orthop Res Soc. 1998. 597s.
  80. Uskoković V. Nanostructured Platforms for the Sustained and Local Delivery of Antibiotics in the Treatment of Osteomyelitis. Crit Rev Ther Drug Carrier Syst. 2015; 32(1):1-59.
  81. Uskoković V., Hoover C., Vukomanović M., Uskoković D.P., Desai T.A. Osteogenic and Antimicrobial Nanoparticulate Calcium Phosphate and Poly-(D, L-Lactide-co-Glycolide) Powders for the Treatment of Osteomyelitis. Mater Sci Eng C Mater Biol Appl. 2013; 33(6):3362-3373.
  82. Winkler H., Janata O., Berger C., Wein W., Georgopoulos A. In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J Antimicrob Chemother. 2000; 46(3):423-428.
  83. Winkler H. Rationale for one stage exchange of infected hip replacement using uncemented implants and antibiotic impregnated bone graft. Int J Med Sci. 2009; 6(5):247-52.
  84. Winkler H., Stoiber A., Kaudela K., Winter F., Menschik F. One stage uncemented revision of infected total hip replacement using cancellous allograft bone impregnated with antibiotics. Bone Joint Surg Br. 2008; 90(12);1580-1584.
  85. Witsø E., Persen L., Benum P., Aamodt A., Husby O.S., Bergh K. High local concentrations without systemic adverse effects after impaction of netilmicin-impregnated bone. Acta Orthop Scand. 2004; 75 (3):339-373.
  86. Wu Wen-Shiann, Chen Chi-Chung, Chuang Yin-Ching, Su Bo-An, Chiu Yu-Hsin, Hsu Hui-Jine, Ko Wen-Chien, Tang Hung-Jen. Efficacy of combination oral antimicrobial agents against biofilm-embedded methicillin-resistant Staphylococcus aureus. Journal of Microbiology. Immunology and Infection. 2013; (46):89-95.
  87. Zilberman M., Elsner J.J. Antibiotic-eluting medical devices for various applications. Journal of Controlled Release. 2008; (130):202-215.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 82474 от 10.12.2021.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies